Metabolism

Tirzepatide

Dual-pathway weight management.

$249/mo

Dual GIP/GLP-1 receptor agonist

1 vial, a 3-month supply. One charge of $747.

Tirzepatide is a dual GIP and GLP-1 receptor agonist for clinically significant weight loss and metabolic health support. Weekly subcutaneous injection.

Start your intake See full formulary

Reviewed by Dr. Rachel Deutsch, DNP · LegitScript certified · No charge until Dr. Rachel approves.